leisure time -WSS

leisure time

author：entertainment 2025-09-30 23:07:19 - browse：7698

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Covid isolation guidance eased by the CDC

WSS

Chamber of Commerce, DOJ clash in court over drug prices

Flu vaccine offering decent levels of protection this winter, new data show

International team creates first chimeric human

The struggle to figure out which patients 'deserve' Wegovy

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Akili changes sales model for its ADHD video game treatment

focus

leisure time

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Why getting cancer drugs just got harder for rural patients

How to save PrEP access — and even expand it

Eli Lilly CEO gives to Mike Pence presidential super PAC

Moonlake's readout produced a cash windfall. Risks remain

Obesity now affects over 1 billion people worldwide, study finds

Guidelines to prevent youth baseball injuries need more muscle

AstraZeneca loses challenge to Medicare drug price negotiation

United colonoscopy coverage change 'may cost lives,' doctors say

The unintended consequences of overturning Roe v. Wade

focus

An inside look at PIPEs, biotech's buzzy new financing tool

FDA does about

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

People with substance use disorder deserve online privacy

FDA weighs limits of animal data in assessing artificial wombs

Why the quest to eradicate polio has stumbled

leisure time

entertainment

hotspot

knowledge